Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complications of long-term anticoagulation.

G W Petty1, L Lennihan, J P Mohr

  • 1Department of Neurology, Neurological Institute, New York, NY 10032.

Annals of Neurology
|June 1, 1988
PubMed
Summary

Long-term warfarin treatment carries a low risk of serious complications and death, with cumulative risks reaching 7% by three years. Patient age and minor complications did not significantly increase these risks during anticoagulation therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A scoping review of dental practitioners' perspectives on perceived barriers and facilitators to preventive oral health care in general dental practice.

BMC oral health·2024
Same author

Impacts of metal mining on river systems: a global assessment.

Science (New York, N.Y.)·2023
Same author

Do routine outcome monitoring measures tell the same story? Evaluating outcome trajectories and clinical outcomes for the outcome rating scale and outcome questionnaire - 45.

Psychotherapy research : journal of the Society for Psychotherapy Research·2023
Same author

Bayesian emulation and history matching of JUNE.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2022
Same author

Reflection on the proposed changes to dose quantities-an industrial perspective.

Journal of radiological protection : official journal of the Society for Radiological Protection·2021
Same author

Bone infection: a clinical priority for clinicians, scientists and educators.

European cells & materials·2021

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Biostatistics

Background:

  • Warfarin is a widely used anticoagulant for preventing thromboembolic events.
  • Long-term warfarin therapy necessitates careful monitoring to manage risks of bleeding and other complications.
  • Understanding the cumulative risks associated with warfarin is crucial for patient management in anticoagulation clinics.

Purpose of the Study:

  • To determine the long-term risks of morbidity and mortality associated with warfarin treatment.
  • To evaluate the impact of patient age and minor complications on the risk of major adverse events.
  • To compare risks between patients treated for cerebrovascular disease versus other indications.

Main Methods:

  • Life-table techniques were employed to calculate cumulative risks.

Related Experiment Videos

  • Cox regression analysis was used to assess the influence of age on complication risks.
  • Data were collected from patients attending an anticoagulation clinic.

    • Main Results:

    • Cumulative risks for life-threatening complications and warfarin-related death were 1% at 6 months, 5% at 1 year, and 7% at 2-3 years.
    • Age did not significantly affect the cumulative risks of complications.
    • Minor complications did not predict the occurrence of major complications or death.

    Conclusions:

    • Long-term warfarin therapy in an anticoagulation clinic setting demonstrates manageable cumulative risks for serious complications and mortality.
    • Patient age and prior minor complications are not significant predictors of major adverse events during warfarin treatment.
    • The indication for anticoagulation (cerebrovascular disease vs. others) did not significantly alter the risk profile.